Hyderabad-based Natco Pharma fired the first shot in the new semaglutide generics market on Friday, launching its brands Semanat and Semafull starting at 1,290 per month in vial dosage form
*Pricing is based on the starting dose
Glucagon-like peptide-1 receptor agonists and diabetic retinopathy: nationwide cohort and Mendelian randomization studies
Current Treatments for ASUDs There is a range of treatments for ASUDs, including behavioral treatments (eg, brief interventions, contingency management, motivational interviewing, motivational enhancement therapy, cognitive behavioral therapy), as well as pharmacological treatments
Neurodegenerative Disorders One of the critical pathological features of neurodegenerative disorders is protein misfolding and aggregation
Over the last 30 years, we have won thousands of SSDI and SSI claims